Clinical Trial Update: Ciprofol's Impact on Oxygenator Function in Extracorporeal Membrane Oxygenation (ECMO) Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Ciprofol's impact on oxygenator function in ECMO patients with ARDS and related cardiopulmonary conditions. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Myocardial Infarction
• Respiratory Distress Syndrome
• Respiratory Failure

Drugs mentioned

• Ciprofol (ciprofol)

Snippet

Sponsor: First Affiliated Hospital of Wannan Medical College | Conditions: ECMO Treatment, ARDS (Acute Respiratory Distress Syndrome) | Phase 4 | Status: NOT_YET_RECRUITING